Medical
New Survey Reveals Cannabis Edibles Outpace Traditional Sleep Aids
A recent survey conducted by The Harris Poll for Green Thumb Industries’ (CSE: GTII, OTCQX: GTBIF) cannabis brand incredibles has unveiled a significant shift in...
Calidi Biotherapeutics to Showcase Innovative Systemic Virotherapy Data at AACR 2025
Calidi Biotherapeutics Inc. (NYSE American: CLDI), a clinical-stage biotechnology firm focused on developing advanced antitumor virotherapies, has announced that its research abstract titled “Development of...
Calidi Biotherapeutics Secures $4.25 Million in Public Offering to Advance Cancer Immunotherapy
Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI), a clinical-stage biotechnology firm specializing in targeted immunotherapies, has successfully priced its public offering of 5,000,000 shares of common...
Vaso Corporation Strengthens Leadership Team with Key Appointments
Vaso Corporation (OTCQX: VASO), a prominent player in human capital, information technology, and MedTech, has announced significant changes to its executive leadership team and Board...
Silo Pharma Secures US Patent for Innovative PTSD Treatment and Gears Up for Clinical Trials
Silo Pharma, Inc. (Nasdaq: SILO), a biopharmaceutical company focused on developing novel therapies for psychiatric disorders, has recently received a Notice of Allowance from the...
Fort Wayne Medical Oncology and Hematology Partners with American Oncology Network to Enhance Cancer Care
In a significant development for cancer care in northeastern Indiana, Fort Wayne Medical Oncology and Hematology (FWMOH) has officially joined the American Oncology Network (AON)...
USDA Set to Gather Key Data on Hemp Industry with 2024 Survey Launch
The United States Department of Agriculture (USDA) is set to conduct a significant survey aimed at gathering critical data on the hemp industry, with the...
Cancer and Blood Specialists of Arizona and American Oncology Network Welcome Dr. Ronak Rakesh Shah
Cancer and Blood Specialists of Arizona (CBSA), a prominent community oncology practice affiliated with the American Oncology Network (AON – OTCQX: AONC), has announced the...
TC BioPharm Moves Forward with ACHIEVE Phase 2b Clinical Trial: Final Dosing Completed for Three Patients
TC BioPharm (Holdings) PLC (NASDAQ: TCBP), a clinical-stage biotechnology company specializing in allogeneic gamma-delta T cell therapies, has made notable progress in its ACHIEVE Phase...
Charlotte’s Web Updates on DeFloria’s Phase 1 Clinical Trial Results for Autism Spectrum Disorder
Charlotte’s Web Holdings, Inc. (TSX: CWEB, OTCQX: CWBHF) has announced significant progress in its collaboration with DeFloria LLC, particularly regarding the clinical development of AJA001,...